Jia Liu, PhDUniversity of Arkansas for Medical Science2016 Cookie Laughlin Bridge Funding Award Myxoma Virus in Combination with Chemotherapy for Treatment of Ovarian Cancer Resistance to chemotherapy occurs in the vast majority of women diagnosed with ovarian cancer and is a major barrier for effective treatment of the disease. Additionally, cells called tumor-associated macrophages (TAMs) […]
Read More
Martin Cannon, PhDUniversity of Arkansas for Medical Science Dendritic cell vaccination & inhibition of tumor-associated immune suppression Recent clinical studies have found that ovarian cancer patients with Th17 lymphocyte infiltrates in tumors enjoy a markedly longer overall survival, suggesting that Th17 cells play a protective role against ovarian cancer. Dr. Cannon designed an innovative approach […]
Read MoreStarting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).
